SEC Form 4 · accession 0001209191-16-096455
MARRONE BIO INNOVATIONS INC · MBII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pamela G Marrone
Officer — CEO and President · Director
Period of report
Feb 5, 2016
Accepted (ET)
Feb 8, 2016 · 5:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001441693
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 5, 2016 | M | 33,378 | $0.47 | A | 785,309 | D | |
| Common Stock | holding | — | — | — | 53,134 | I | Jointly with Spouse | |
| Common StockF1 | holding | — | — | — | 6,442 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $0.47 | Feb 5, 2016 | M | 33,378 | D | — | May 1, 2017 | Common Stock | 33,378 | 0 | D |
Explanation of responses
- F1Ownership is held by Florence H. Marrone TOD Pamela G. Marrone.
- F2The options vested with respect to 25% of the total 53,378 shares subject to the option on the grant date of May 1, 2007, with 2.083% of the total shares subject to the option vesting monthly thereafter.